Robeco Institutional Asset Management B.V. Purchases New Shares in Henry Schein, Inc. (NASDAQ:HSIC)

Robeco Institutional Asset Management B.V. acquired a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 11,033 shares of the company's stock, valued at approximately $763,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Marshall Wace LLP bought a new stake in shares of Henry Schein in the 2nd quarter valued at approximately $851,000. Millennium Management LLC raised its position in Henry Schein by 287.7% during the second quarter. Millennium Management LLC now owns 146,877 shares of the company's stock valued at $9,415,000 after acquiring an additional 108,988 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its position in Henry Schein by 84.0% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 3,189 shares of the company's stock valued at $204,000 after acquiring an additional 1,456 shares in the last quarter. Sanctuary Advisors LLC bought a new position in Henry Schein during the second quarter valued at approximately $351,000. Finally, Czech National Bank raised its position in Henry Schein by 5.8% during the third quarter. Czech National Bank now owns 25,811 shares of the company's stock valued at $1,882,000 after acquiring an additional 1,409 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Insiders Place Their Bets

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.14% of the company's stock.

Henry Schein Stock Performance

HSIC stock traded down $0.85 on Friday, reaching $79.00. 1,141,263 shares of the company were exchanged, compared to its average volume of 1,474,978. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.63. The stock's fifty day moving average price is $73.70 and its 200 day moving average price is $71.78. The firm has a market capitalization of $9.85 billion, a PE ratio of 32.51, a PEG ratio of 2.21 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same quarter in the previous year, the firm posted $1.32 earnings per share. Henry Schein's revenue was up .4% compared to the same quarter last year. On average, research analysts anticipate that Henry Schein, Inc. will post 4.76 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on HSIC shares. Jefferies Financial Group raised their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research report on Thursday, January 23rd. Barrington Research raised their price objective on shares of Henry Schein from $82.00 to $90.00 and gave the company an "outperform" rating in a research report on Thursday, January 30th. Mizuho initiated coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 price target on the stock. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and lifted their price target for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Finally, StockNews.com raised shares of Henry Schein from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Seven research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Henry Schein currently has a consensus rating of "Moderate Buy" and a consensus price target of $80.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.